Duoneb and Pomalyst drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duoneb (albuterol sulfate; ipratropium bromide) and Pomalyst (pomalidomide). Common drug interactions include pneumonia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Duoneb and Pomalyst. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Pomalyst?

Pomalyst has active ingredients of pomalidomide. eHealthMe is studying from 80,400 Pomalyst users. Check the latest studies of Pomalyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

58 people who take Duoneb and Pomalyst together, and have interactions are studied.

What are the common drug interactions of Duoneb and Pomalyst, by gender? *:

female:

Pneumonia
Malaise (a feeling of general discomfort or uneasiness)
Plasma cell myeloma (cancer that begins in plasma cells)
Influenza
Arrhythmia (irregular heartbeat)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Rash
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

male:

Pneumonia
Dizziness
Skin wrinkling (wrinkle on skin)
Chills (felling of cold)
Fatigue (feeling of tiredness)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Platelet count decreased
Rash
Seasonal allergy (allergic condition due to certain season)

What are the common drug interactions of Duoneb and Pomalyst, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood pressure increased
Infusion related reaction
Oxygen saturation decreased

50-59:

Pneumonia
Skin wrinkling (wrinkle on skin)
Pain
Respiratory syncytial virus infection (viral disease of respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

Pneumonia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Fatigue (feeling of tiredness)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Haematuria (presence of blood in urine)
Hypercalcaemia of malignancy (elevated calcium (ca+) level in the blood with cancer)
Asthenia (weakness)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Constipation

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 53 people, 91.38%
Pain: 7 people, 12.07%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 10.34%
Dyspnea (difficult or laboured breathing): 6 people, 10.34%
High Blood Pressure: 5 people, 8.62%
Cough: 5 people, 8.62%
Type 2 Diabetes: 3 people, 5.17%
Joint Pain: 3 people, 5.17%
Diarrhea: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and Pomalyst?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously